RadNet Q2 2026 earnings show revenue of $622.7M, up 25% YoY, with digital health revenue soaring 56.5%. Full-year guidance raised amid strong procedural growth.
RadNet, Inc. reported Q2 2026 revenue of $622.7 million, a 25% increase from $498.2 million in the same quarter last year, surpassing consensus estimates. This significant growth was primarily driven by increased procedural volumes in advanced imaging and a strong performance from the company's digital health segment, prompting management to raise full-year guidance for revenue and EBITDA.
Key Takeaways
- Total Revenue for Q2 2026 was $622.7 million, up 25% year-over-year, beating the consensus estimate.
- Adjusted EBITDA rose 22.7% to $99.7 million compared to $81.2 million in the prior year.
- Digital Health Revenue surged 56.5% to $32.4 million, driven by robust growth in AI and enterprise imaging solutions.
- Advanced Imaging Volumes increased significantly, with MRI and PET CT procedures up 21% and 31%, respectively, from a year ago.
- Full-Year Guidance for imaging center revenue was raised to $2.37 billion to $2.42 billion, with adjusted EBITDA guidance updated to $345 million to $358 million.
Strong Revenue Growth Driven by Advanced Imaging
Total company revenue hit a record of $622.7 million, growing 25% year-over-year and 4% sequentially. This growth can be attributed to a notable uptick in advanced imaging procedural volumes, which saw aggregate MRI volumes increase by 21%, same center volumes by 10%, and PET CT volumes soar by 31%. Advanced imaging now accounts for 29.9% of total procedural volume, a significant increase from 27.5% in Q2 2025. The company’s operational focus on improving imaging center efficiency and capacity has contributed to this favorable trend.
| Metric | Q2 2026 | YoY | QoQ |
|---|---|---|---|
| Revenue | $622.7M | +25% | +4% |
| Adjusted EBITDA | $99.7M | +22.7% | +3% |
Digital Health Segment Sees Rapid Expansion
RadNet's digital health segment reported revenue of $32.4 million, up 56.5% year-over-year, with notable contributions from AI solutions and enterprise imaging. The annual recurring revenue (ARR) for the digital health segment reached $105.5 million, marking a 97% increase year-over-year. The company is on track to achieve full-year ARR growth expectations of 91%, with significant opportunities arising from ongoing partnerships across North America and Europe.
Management highlighted that about 63% of ARR now comes from external sources, indicating a healthy expansion strategy. Additionally, the integration of recent acquisitions has positioned the segment for further growth, aiming for a profitability trajectory that aligns with RadNet's overall objectives.
Guidance Raised Amid Positive Trends
Given the strong performance in Q2, RadNet has raised its full-year guidance for imaging center revenue to a range of $2.37 billion to $2.42 billion, up from previous estimates. Adjusted EBITDA guidance was also increased to $345 million to $358 million. Additionally, free cash flow guidance was updated to $115 million to $125 million, reflecting the company's strengthened financial position and operational efficiencies.
This proactive adjustment in guidance underscores management's confidence in the sustained demand for advanced imaging services and digital health solutions, positioning the company favorably for the second half of the year.
Analyst Q&A Reveals Insights on Future Opportunities
During the Q&A session, analysts inquired about the sustainability of recent margin improvements and the ongoing labor challenges in the industry. Management acknowledged that while the company faces inflationary pressures, particularly in staffing, the strategic investments in technology and operational efficiencies are expected to enhance margins moving forward. They pointed out that the ongoing integration of acquired entities and the rollout of digital health solutions will contribute to long-term margin expansion.
Additionally, management indicated that they are exploring both imaging and digital health acquisition opportunities, emphasizing a strategic focus on partnerships that can drive operational efficiencies and enhance their market position. The growing interest from health systems in outpatient imaging solutions further supports this expansion strategy.
Frequently Asked Questions
Did RadNet, Inc. Common Stock beat earnings estimates in Q2 2026?
Yes, RadNet reported revenue of $622.7 million for Q2 2026, exceeding consensus estimates.
What was the adjusted EBITDA for RadNet in Q2 2026?
Adjusted EBITDA for Q2 2026 was $99.7 million, a 22.7% increase compared to the same quarter last year.
How much did digital health revenue grow in Q2 2026?
Digital health revenue grew 56.5% year-over-year to $32.4 million in Q2 2026.
What is RadNet's outlook for the rest of 2026?
RadNet has raised its full-year guidance for revenue to between $2.37 billion and $2.42 billion, signaling confidence in continued growth.
In conclusion, RadNet's robust Q2 performance reflects strong demand across its imaging services and strategic advancements in digital health solutions. The next quarter will be critical for assessing the sustainability of these growth trends and the company's ability to navigate ongoing market challenges.
This analysis is based on public earnings call materials and is not investment advice.
